|
Volumn 110, Issue 4, 2000, Pages 819-825
|
Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells
|
Author keywords
Ara C; ATM; Doxorubicin; HL 60; Intra S phase checkpoint
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ATM PROTEIN;
BROXURIDINE;
CAFFEINE;
CELL DNA;
CYTARABINE;
DNA TOPOISOMERASE INHIBITOR;
DOXORUBICIN;
ETOPOSIDE;
GENE PRODUCT;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ATAXIA TELANGIECTASIA;
CELL CYCLE G2 PHASE;
CELL CYCLE S PHASE;
CELL STRAIN HL 60;
CONTROLLED STUDY;
DNA DETERMINATION;
DRUG LABELING;
GENE MUTATION;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
LYMPHOBLASTOID CELL;
NICK END LABELING;
NONHUMAN;
PRIORITY JOURNAL;
YEAST CELL;
ANTIMETABOLITES;
ANTINEOPLASTIC AGENTS;
BROMODEOXYURIDINE;
CAFFEINE;
CELL CYCLE PROTEINS;
CELL LINE, TRANSFORMED;
CYTARABINE;
DNA TOPOISOMERASES, TYPE II;
DNA-BINDING PROTEINS;
DOXORUBICIN;
ETOPOSIDE;
FLOW CYTOMETRY;
GENE EXPRESSION;
HL-60 CELLS;
HUMANS;
MUTATION;
PHOSPHODIESTERASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
S PHASE;
SIGNAL TRANSDUCTION;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 0033755017
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2000.02304.x Document Type: Article |
Times cited : (11)
|
References (40)
|